RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513,558 | -11.1% | 30,900 | 0.0% | 0.00% | – |
| Q2 2023 | $577,830 | +1.9% | 30,900 | 0.0% | 0.00% | – |
| Q1 2023 | $567,015 | -7.3% | 30,900 | 0.0% | 0.00% | – |
| Q4 2022 | $611,820 | -9.5% | 30,900 | +10.0% | 0.00% | – |
| Q3 2022 | $676,000 | +31.8% | 28,100 | 0.0% | 0.00% | – |
| Q2 2022 | $513,000 | -17.0% | 28,100 | 0.0% | 0.00% | – |
| Q1 2022 | $618,000 | -39.9% | 28,100 | +0.4% | 0.00% | – |
| Q4 2021 | $1,028,000 | +18.3% | 28,000 | 0.0% | 0.00% | – |
| Q3 2021 | $869,000 | -2.4% | 28,000 | 0.0% | 0.00% | – |
| Q2 2021 | $890,000 | +174.7% | 28,000 | +91.8% | 0.00% | – |
| Q1 2021 | $324,000 | +12.5% | 14,600 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | -38.7% | 14,600 | 0.0% | 0.00% | – |
| Q3 2020 | $470,000 | +22.7% | 14,600 | +10.6% | 0.00% | – |
| Q2 2020 | $383,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |